CureVac Statistics, Revenue Totals and Facts (2021)



Here are a few of the most interesting CureVac statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.

CureVac Facts

  • Website: Official Website
  • Year Founded: 2000
  • Headquarters: Tubingen, Germany
  • Founder(s): Ingmar Hoerr
  • Current Chief Executive: Franz-Werner Haas

What is CureVac?

CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases. Based on its proprietary technology, the Company has built a deep clinical pipeline across the areas of prophylactic vaccines, cancer therapies, antibody therapies, and the treatment of rare diseases. CureVac had its initial public offering on the New York Nasdaq in August 2020. It is headquartered in Tübingen, Germany, and employs more than 600 people at its sites in Tübingen, Frankfurt, and Boston, USA. (source)

CureVac Employee Count

Number of CureVac employees:

400 employees

Last updated 3/14/20


CureVac Statistics

 

Total amount of funding raised by CureVac:

$420 million

Last updated 6/13/19


Please note that some of these numbers are easier to find than others. A few of these CureVac stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.